Cancer treatment

Cancer

Evaluation of Feasibility of Response Adapted Stereotactic Ablative Body Radiotherapy in Melanoma

Researchers at the Icon Cancer Foundation have initiated a clinical trial to evaluate the feasibility of response-adapted or response-and-anatomical-adapted Stereotactic Ablative Body Radiotherapy (SABR) in patients with advanced melanoma receiving immunotherapy. The trial, registered with the Australian New Zealand Clinical Trials Registry (ANZCTR) as ACTRN12624001299594, aims to develop a method

Cancer treatment

RNA Therapies Poised to Revolutionize Medicine with Promising Results and Growing Market

The latest report from Novotech, a global full-service clinical Contract Research Organization, highlights the transformative potential of RNA therapies in modern medicine. With their highly-targeted mechanisms and versatility, RNA-based treatments have transitioned from a novel concept to a promising frontier in disease treatment. The report details the current landscape, advancements,

Cancer

Personalized Medicine Breakthrough: Mutations in * * FBXW7* * and * * SMAD4* * Predict Clinical Outcome in Metastatic Colorectal Cancer

A new study published in the journal Cancers has made a significant breakthrough in personalized medicine, identifying mutations in * * FBXW7* * and * * SMAD4* * as predictors of clinical outcome in metastatic colorectal cancer. The research, conducted by a team of scientists from the University of Barcelona, used next-generation sequencing (NGS) to analyze